Predictors of early mortality in veteran patients with pancreatic cancer.
暂无分享,去创建一个
[1] Douglas B. Evans,et al. Prognostic factors in patients with unresectable locally advanced pancreatic adenocarcinoma treated with chemoradiation , 2006, Cancer.
[2] T. Ertan,et al. Value of preoperative serum CA 19-9 levels in predicting resectability for pancreatic cancer. , 2006, Canadian journal of surgery. Journal canadien de chirurgie.
[3] A. Jemal,et al. Cancer Statistics, 2006 , 2006, CA: a cancer journal for clinicians.
[4] I. Schmid,et al. Effects of soluble TNF receptor II (sTNF-RII), IL-1 receptor antagonist (IL-1ra), tumor load and hypermetabolism on malnutrition in children with acute leukemia. , 2005, European journal of medical research.
[5] F. Gansauge,et al. Treatment of Pancreatic Cancer: Challenge of the Facts , 2003, World Journal of Surgery.
[6] R. Parks,et al. Prognostic factors in the palliation of pancreatic cancer. , 2003, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[7] C. McArdle,et al. Albumin Concentrations Are Primarily Determined by the Body Cell Mass and the Systemic Inflammatory Response in Cancer Patients With Weight Loss , 2001, Nutrition and cancer.
[8] H. Ueno,et al. Prognostic Factors in Patients with Metastatic Pancreatic Adenocarcinoma Receiving Systemic Chemotherapy , 2000, Oncology.
[9] D. Gouma,et al. Pooling of prognostic studies in cancer of the pancreatic head and periampullary region: the Triple-P study. Triple-P study group. , 2000, The European journal of surgery = Acta chirurgica.
[10] A. Vigano,et al. Clinical survival predictors in patients with advanced cancer. , 2000, Archives of internal medicine.
[11] K. Lillemoe,et al. Is prophylactic gastrojejunostomy indicated for unresectable periampullary cancer? A prospective randomized trial. , 1999, Annals of surgery.
[12] J. Cubiella,et al. Prognostic factors in nonresectable pancreatic adenocarcinoma: a rationale to design therapeutic trials , 1999, American Journal of Gastroenterology.
[13] C. Su,et al. Diagnostic and prognostic values of CA 19-9 and CEA in periampullary cancers. , 1999, Journal of the American College of Surgeons.
[14] T. Ponchon,et al. Predictive factors for survival of patients with inoperable malignant distal biliary strictures: a practical management guideline , 1998, Gut.
[15] J. Ross,et al. Acute‐phase protein response and survival duration of patients with pancreatic cancer , 1995, Cancer.
[16] D. Bajorin,et al. Prognostic factors in patients with metastatic malignant melanoma: A multivariate analysis , 1993, Cancer.
[17] T. Nishimura,et al. Indentificattion of Colony-stimulating Factor Activity in Patients with Malignant Tumors Associated with Excessive Leukocytois , 1991 .
[18] M. Izuo,et al. [Colony stimulating factor producing carcinoma of the pancreas--a case report]. , 1989, Gan no rinsho. Japan journal of cancer clinics.
[19] J. Zech,et al. [Prognostically relevant factors in ductal pancreatic cancer]. , 1989, Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen.
[20] Y. Ku,et al. Predicting factors for survival of patients with unresectable pancreatic cancer: a management guideline. , 2003, Hepato-gastroenterology.
[21] W. Henderson,et al. Preoperative serum albumin level as a predictor of operative mortality and morbidity: results from the National VA Surgical Risk Study. , 1999, Archives of surgery.